An analysis of data from 12 studies involving nearly 20,000 women found that taking aspirin daily was tied to a 20% reduced risk for developing ovarian cancer, compared with using the drug less than weekly. The study, published in the Journal of the National Cancer Institute, found no link between acetaminophen intake and ovarian cancer risk. An association between non-aspirin nonsteroidal anti-inflammatory drugs such as naproxen and reduced ovarian cancer risk was not found to be significant.

Full Story:
HealthDay News

Related Summaries